Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol in Adults and Adolescents With ASD
NCT02414451Withdrawn
- Sponsor
- University of Missouri
- Start
- Sep 2016
- Primary completion
- Sep 2016
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in Autism Spectrum Disorder (ASD) comparing Propranolol arm with Placebo arm (2 arms). Primary endpoints: General Social Outcome Measure at 19 weeks and Social Responsiveness Scale at 19 weeks. Planned start Sep 2016; status: withdrawn.
02
Drugs
propranolol
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT02414451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02414451.